A Study to Evaluate CJC 1295 in HIV Patients With Visceral Obesity
NCT00267527
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
120
Enrollment
INDUSTRY
Sponsor class
Conditions
Obesity
HIV Infections
Interventions
DRUG:
CJC 1295
Sponsor
ConjuChem